Cargando…
Fingolimod: Lymphopenia and COVID-19 infection complicated by pneumonia: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348128/ http://dx.doi.org/10.1007/s40278-020-80604-9 |
Ejemplares similares
-
Cladribine/hydroxychloroquine: COVID-19-pneumonia, lymphopenia and off label use: case report
Publicado: (2020) -
Methotrexate/steroids: Lymphopenia and Pneumocystis pneumonia: case report
Publicado: (2021) -
COVID-19-vaccine/mycophenolate: Cytomegalovirus infection and lymphopenia: case report
Publicado: (2022) -
Alemtuzumab/cladribine/natalizumab: Lymphopenia and COVID-19 infection: case report
Publicado: (2021) -
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis
por: Ohtani, Ryohei, et al.
Publicado: (2018)